Neo-MASCT Immunotherapy for Advanced NSCLC.
Clinical trial NCT03205930 · UNKNOWN
Trial details
- NCT number
- NCT03205930
- Sponsor
- The First People's Hospital of Lianyungang
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2019-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.